CLEAR PHARMACY (CREWE) LIMITEDActive

Company number 08514917Private limited companyIncorporated 2013

Key figures

−£379,775-44.1%
Net assets 2024/25
-400 k-200 k0200 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, CLEAR PHARMACY (CREWE) LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0500 k1 m2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand1,424141,8614,3171,4931,605
Total assets520,198509,782415,500385,775399,861
Total liabilities457,903490,457514,852643,909773,374
Net assets / total equity62,29513,063-105,614-263,475-379,775
Average number of employees1012191717

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: CLEAR PHARMACY (CREWE) LIMITED

Company

CLEAR PHARMACY (CREWE) LIMITED is a private limited company registered with Companies House under company number 08514917. It was incorporated on 2 May 2013. Its status is active. The registered office is in Widnes (WA8). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Jan 2025); the company files abridged accounts (unaudited). Net assets were −£379,775, down 44.1% on the previous year. Cash at bank and in hand was £1,605. Total assets were £399,861 and total liabilities £773,374. The company had an average of 17 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

2 persons with significant control are registered. 1 of 1 registered charges are outstanding.

Filing deadlines

The next accounts are due by 31 Oct 2026. The next confirmation statement is due by 16 May 2027.